Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
Faroogh Marofi, Heshu Sulaiman Rahman, Muhammad Harun Achmad, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Axicabtagene ciloleucel versus tisagenlecleucel for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis
Nico Gagelmann, Michael R. Bishop, Francis Ayuk, et al.
Transplantation and Cellular Therapy (2024)
Open Access | Times Cited: 18
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021
Lele Miao, Juan Zhang, Zhengchao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Bispecific Antibodies in Hematological Malignancies: A Scoping Review
Mohamed H. Omer, Areez Shafqat, Omar Ahmad, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4550-4550
Open Access | Times Cited: 18
Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
Maria Florencia Giraudo, Zachary Jackson, Indrani Das, et al.
Pathogens and Immunity (2024) Vol. 9, Iss. 1, pp. 1-17
Open Access | Times Cited: 8
CAR-T cell-derived exosomes: a new perspective for cancer therapy
Farnaz Sani, Shabnam Shojaei, Seyed Amirhossein Tabatabaei, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Post-translational modifications and immune responses in liver cancer
Youwei Wang, Jiachen Zuo, Chong Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy
Meng Su, Luoquan Chen, Lihua Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
“Attack!” Cellular Therapies to Attack Pathogens and Tumors
Britta Eiz‐Vesper, Halvard Bönig
Transfusion Medicine and Hemotherapy (2025) Vol. 52, Iss. 1, pp. 1-4
Open Access
Exploration of Euscaphic Acid on Non-Hodgkin Lymphoma Based on Network Pharmacology, Molecular Docking and Cell Experiment
Guangru Li, Ruiting Wen, Yan Liu, et al.
Natural Product Communications (2025) Vol. 20, Iss. 3
Open Access
Evaluation of NHL subtypes, staging, and prognostic factors: A single-centric retrospective cohort study
Ulfat Ara Wani, Umeek Jeelani, Sheikh Aejaz Aziz, et al.
Journal of Cancer Research and Therapeutics (2025) Vol. 21, Iss. 1, pp. 34-39
Open Access
Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
Mikel Etxebeste-Mitxeltorena, Inés del Rincón-Loza, Beatriz Martín-Antonio
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
CD14−CD10−CD45+HLA‐DR−SSC+ neutrophils may be granulocytic myeloid‐derived suppressor cell–like cells and relate to disease progression in non‐Hodgkin's lymphoma patients
Ji Zhou, Hao Xiao, Zhitao Wang, et al.
Immunology and Cell Biology (2024) Vol. 102, Iss. 4, pp. 256-268
Closed Access | Times Cited: 2
Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma
Or Atar, Ron Ram, Irit Avivi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 908-908
Open Access | Times Cited: 6
Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies
Wioletta Olejarz, Grzegorz Basak
Cancers (2023) Vol. 15, Iss. 24, pp. 5765-5765
Open Access | Times Cited: 6
Immunotherapy in indolent Non-Hodgkin's Lymphoma
Ghid Amhaz, Ali Bazarbachi, Jean El Cheikh
Leukemia Research Reports (2022) Vol. 17, pp. 100325-100325
Open Access | Times Cited: 10
Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
Zhaoqi Chen, Yan Liu, Nianci Chen, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 754-770
Open Access | Times Cited: 10
Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma
Frédérique St‐Pierre, Leo I. Gordon
Future Oncology (2023) Vol. 19, Iss. 1, pp. 19-28
Closed Access | Times Cited: 5
CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma
Magdalena Ostojska, Emilia Nowak, Julia Twardowska, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1595-1595
Open Access | Times Cited: 5
Potential of chimeric antigen receptor (CAR)‐redirected immune cells in breast cancer therapies: Recent advances
Marzieh Nikoo, Mohammad Rudiansyah, Dmitry Olegovich Bokov, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 15, pp. 4137-4156
Open Access | Times Cited: 8
Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches
Walter Hanel, Alex F. Herrera, Narendranath Epperla
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Oncology nurse competency in chimeric antigen receptor T-cell therapy: A qualitative study
Jin He, Jing Li, Feng Li, et al.
Nurse Education Today (2023) Vol. 132, pp. 106040-106040
Closed Access | Times Cited: 4
The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
Justyna Derebas, Kinga Panuciak, Mikołaj Margas, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1569-1569
Open Access | Times Cited: 7
The clinical applications of immunosequencing
B. Bardwell, Jacques Olivier Bay, Zachary Colburn
Current Research in Translational Medicine (2024) Vol. 72, Iss. 3, pp. 103439-103439
Closed Access | Times Cited: 1
Advances in the treatment of relapsed/refractory marginal zone lymphoma
Haotian Wang, Xin Wan, Ying Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas
Sha Zhou, Jun Rao, Xiang-Yu Ma, et al.
International Journal of Hematology (2024) Vol. 120, Iss. 1, pp. 96-105
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top